+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2020

  • ID: 5137284
  • Drug Pipelines
  • July 2020
  • Region: Global
  • 218 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Alloksys Life Sciences BV
  • CFM Pharma Holding BV
  • F. Hoffmann-La Roche Ltd
  • Meridigen Biotech Co Ltd
  • Pharming Group NV
  • Renibus Therapeutics Inc
  • MORE
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2020

Summary

The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure - Pipeline Review, H2 2020, provides an overview of the Acute Renal Failure (Genito Urinary System And Sex Hormones) pipeline landscape.

Acute kidney failure occurs when kidneys suddenly become unable to filter waste products from blood. Symptoms include drowsiness, shortness of breath, fatigue, seizures or coma in severe cases and chest pain. The predisposing factors include age, diabetes, high blood pressure, heart failure and kidney diseases. Treatment includes antibiotics and diuretics.

Report Highlights

The publisher's Pharmaceutical and Healthcare latest pipeline guide Acute Renal Failure - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Acute Renal Failure (Genito Urinary System And Sex Hormones), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Acute Renal Failure (Genito Urinary System And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 3, 6, 10, 34 and 7 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 5 molecules, respectively.

Acute Renal Failure (Genito Urinary System And Sex Hormones) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Acute Renal Failure (Genito Urinary System And Sex Hormones).
  • The pipeline guide reviews pipeline therapeutics for Acute Renal Failure (Genito Urinary System And Sex Hormones) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Acute Renal Failure (Genito Urinary System And Sex Hormones) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Acute Renal Failure (Genito Urinary System And Sex Hormones) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Acute Renal Failure (Genito Urinary System And Sex Hormones)
Reasons to Buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Acute Renal Failure (Genito Urinary System And Sex Hormones).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Acute Renal Failure (Genito Urinary System And Sex Hormones) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alloksys Life Sciences BV
  • CFM Pharma Holding BV
  • F. Hoffmann-La Roche Ltd
  • Meridigen Biotech Co Ltd
  • Pharming Group NV
  • Renibus Therapeutics Inc
  • MORE
  • Introduction
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Overview
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics Development
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Therapeutics Assessment
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Companies Involved in Therapeutics Development
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Drug Profiles
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Dormant Projects
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Discontinued Products
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Product Development Milestones
  • Appendix
List of Tables
  • Number of Products under Development for Acute Renal Failure (ARF) (Acute Kidney Injury), H2 2020
  • Number of Products under Development by Companies, H2 2020
  • Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
  • Number of Products under Development by Companies, H2 2020 (Contd..2), H2 2020
  • Number of Products under Development by Universities/Institutes, H2 2020
  • Products under Development by Companies, H2 2020
  • Products under Development by Companies, H2 2020 (Contd..1), H2 2020
  • Products under Development by Companies, H2 2020 (Contd..2), H2 2020
  • Products under Development by Companies, H2 2020 (Contd..3), H2 2020
  • Products under Development by Universities/Institutes, H2 2020
  • Number of Products by Stage and Target, H2 2020
  • Number of Products by Stage and Target, H2 2020 (Contd..1), H2 2020
  • Number of Products by Stage and Mechanism of Action, H2 2020
  • Number of Products by Stage and Mechanism of Action, H2 2020 (Contd..1), H2 2020
  • Number of Products by Stage and Route of Administration, H2 2020
  • Number of Products by Stage and Molecule Type, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Alloksys Life Sciences BV, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Am-Pharma BV, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Angion Biomedica Corp, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Arch Biopartners Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Axolo Pharma Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Balmes Transplantation SAS, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Bessor Pharma LLC, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Cellmid Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by CFM Pharma Holding BV, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Chaperone Pharma BV, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Cypralis Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by DeckTherapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by DepYmed Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by DURECT Corp, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Evotec SE, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Exponential Biotherapies Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by F. Hoffmann-La Roche Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Goldilocks Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Guard Therapeutics International AB, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by INVENT Pharmaceuticals Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Kalytera Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Kantum Pharma Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Klotho Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Kringle Pharma Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Liminal BioSciences Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by LTT Bio-Pharma Co Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Meridigen Biotech Co Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Mission Therapeutics Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Mitobridge Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Mitotech SA, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Nephraegis Therapeutics, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Paranta Biosciences Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Pharmicell Co Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Pharming Group NV, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Praetego Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Q BioMed Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Quark Pharmaceuticals Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Radikal Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Rediscovery Life Sciences, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Redx Pharma Plc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Renibus Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Sentien Biotechnologies Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Silver Creek Pharmaceuticals Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Spherium Biomed SL, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by STATegics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Sulfateq BV, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by TES Pharma SRL, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by TheraSource LLC, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Theratome Bio Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Torrent Pharmaceuticals Ltd, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Unicycive Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Vasomune Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by vasopharm GmbH, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by Xigen SA, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline by XORTX Therapeutics Inc, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Dormant Projects, H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Dormant Projects, H2 2020 (Contd..1), H2 2020
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Discontinued Products, H2 2020
List of Figures
  • Number of Products under Development for Acute Renal Failure (ARF) (Acute Kidney Injury), H2 2020
  • Number of Products under Development by Companies, H2 2020
  • Number of Products by Top 10 Targets, H2 2020
  • Number of Products by Stage and Top 10 Targets, H2 2020
  • Number of Products by Top 10 Mechanism of Actions, H2 2020
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
  • Number of Products by Top 10 Routes of Administration, H2 2020
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2020
  • Number of Products by Top 10 Molecule Types, H2 2020
  • Number of Products by Stage and Top 10 Molecule Types, H2 2020
Note: Product cover images may vary from those shown
  • Alloksys Life Sciences BV
  • Am-Pharma BV
  • Angion Biomedica Corp
  • Arch Biopartners Inc
  • Axolo Pharma Inc
  • Balmes Transplantation SAS
  • Bessor Pharma LLC
  • Cellmid Ltd
  • CFM Pharma Holding BV
  • Chaperone Pharma BV
  • Cypralis Ltd
  • DeckTherapeutics Inc
  • DepYmed Inc
  • DURECT Corp
  • Evotec SE
  • Exponential Biotherapies Inc
  • F. Hoffmann-La Roche Ltd
  • GeneScience Pharmaceuticals Co Ltd
  • Goldilocks Therapeutics Inc
  • Guard Therapeutics International AB
  • INVENT Pharmaceuticals Inc
  • Kalytera Therapeutics Inc
  • Kantum Pharma Inc
  • Klotho Therapeutics Inc
  • Kringle Pharma Inc
  • Liminal BioSciences Inc
  • LTT Bio-Pharma Co Ltd
  • Meridigen Biotech Co Ltd
  • Mission Therapeutics Ltd
  • Mitobridge Inc
  • Mitotech SA
  • Nephraegis Therapeutics
  • Paranta Biosciences Ltd
  • Pharmicell Co Ltd
  • Pharming Group NV
  • Praetego Inc
  • Q BioMed Inc
  • Quark Pharmaceuticals Inc
  • Radikal Therapeutics Inc
  • Rediscovery Life Sciences
  • Redx Pharma Plc
  • Renibus Therapeutics Inc
  • Sentien Biotechnologies Inc
  • Silver Creek Pharmaceuticals Inc
  • Spherium Biomed SL
  • STATegics Inc
  • Sulfateq BV
  • TES Pharma SRL
  • TheraSource LLC
  • Theratome Bio Inc
  • Torrent Pharmaceuticals Ltd
  • Unicycive Therapeutics Inc
  • Vasomune Inc
  • vasopharm GmbH
  • Xigen SA
  • XORTX Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll